Literature DB >> 8945694

Predicting progression to AIDS. An evaluation of two approaches.

L Rabeneck1, P M Hartigan, I W Huang, J Souchek, N P Wray.   

Abstract

This study evaluated the predictive validity of two clinical staging systems for HIV infection (the Rabeneck and Royce systems) using data obtained from the Department of Veterans Affairs Cooperative Study Number 298, a randomized clinical trial involving 335 symptomatic patients with CD4 counts of 200 to 500/mm3. The relation between the HIV clinical stages and progression to AIDS was examined using Kaplan-Meier estimates, and Cox models were used to determine if the stages remained predictive after controlling for CD4 count. Both systems were significant independent predictors of progression to AIDS. This work demonstrates that simple, valid staging systems for HIV infection can be developed that provide greater prognostic distinction than the CD4 count alone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945694     DOI: 10.1007/bf02599030

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  9 in total

1.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-14

2.  Clinical biostatistics. XIV. The purposes of prognostic stratification.

Authors:  A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

3.  The natural history of HIV-1 infection: staging classifications of disease.

Authors:  R A Royce; R S Luckmann; R E Fusaro; W Winkelstein
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

4.  A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats.

Authors:  L Rabeneck; M M Crane; J M Risser; C E Lacke; N P Wray
Journal:  J Gen Intern Med       Date:  1993-01       Impact factor: 5.128

Review 5.  Predicting the outcomes of human immunodeficiency virus infection. How well are we doing.

Authors:  L Rabeneck; N P Wray
Journal:  Arch Intern Med       Date:  1993-12-27

6.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

Authors:  J D Hamilton; P M Hartigan; M S Simberkoff; P L Day; G R Diamond; G M Dickinson; G L Drusano; M J Egorin; W L George; F M Gordin
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

7.  Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment.

Authors:  M S Simberkoff; P M Hartigan; J D Hamilton; P L Day; G R Diamond; G M Dickinson; G L Drusano; M J Egorin; W L George; F M Gordin; C A Hawkes; P C Jensen; N G Kilmas; A M Labriola; W A O'Brien; C N Oster; K J Weinhold; N P Wray; S B Pazner
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-02-01

8.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.